Recent Company News

• 05:19 AM ET Mar 27, 2026
  

  Genenta Science signs binding offer to take control of Sòphia High Tech for €6.0M ($0.83, 0.00)

• 03:33 AM ET Mar 24, 2026
  

  Genenta Science continues to evaluate strategic options for its biotechnology platform ($0.67, 0.00)

• 09:15 AM ET Oct 27, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:26 AM ET Oct 27, 2025
  

  StreetAccount Summary - US Pre-market trading

• 03:22 AM ET Jan 27, 2026
  

  Genenta to pursue strategy of buying private firms in national-security regulated sectors; to change name to Saentra Forge ($1.30, 0.00)

• 04:08 AM ET Nov 24, 2025
  

  Genenta updates on TEM-GBM study of Temferon ($1.68, 0.00)

• 08:32 PM ET Oct 26, 2025
  

  Genenta Science enters into securities purchase agreement with institutional investors to purchase 4.3M ADSs at $3.50/ADS ($6.20, 0.00)